Publications

5543 Results

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer

Authors
N Altorki;X Wang;D Kozono;C Watt;R Landreneau;D Wigle;J Port;D Jones;M Conti;A Ashrafi;M Lieberman;K Yasufuku;S Yang;J Mitchell;H Pass;R Keenan;T Bauer;D Miller;L Kohman;T Stinchcombe;E Vokes
Journal / Conference
New England Journal of Medicine Feb 9;388(6):489-498
Year
2023
Research Committee(s)
Lung
PMID
PMID36780674

Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials

Authors
M Roth;S Parsons;P Ganz;L Wagner;P Hinds;S Alexander;K Bingen;S Bober;J Brackett;D Cella;NL Henry;D Indelicato;RH Johnson;T Miller;S Rosenberg;K Schmitz;G Thanarajasingam;B Reeve;J Salsman
Journal / Conference
Journal of the National Cancer Institute Jan 10;115(1):21-28
Year
2023
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID36266760
PMC
PMC9830479

Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer

Authors
C Hatcher;G Richenberg;S Waterson;L Nguyen;A Joshi;R Carreras-Torres;V Moreno;A Chen;M Gunter;Y Lin;C Qu;M Song;G Casey;J Figueiredo;S Gruber;J Hampe;H Hampel;M Jenkins;T Keku;U Peters;C Tangen;A Wu;D Hughes;M Ruhlemann;J Raes;N Timpson;K Wade
Journal / Conference
Scientific Reports Apr 12;13(1):5968. doi: 10.1038/s41598-023-31840-0
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37045850
PMC
PMC10097673
Study Number(s)
S0000

Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314

Authors
Y-T Lu;M Plets;G Morrison;A Cunha;S Cen;S Rhie;K Siegmund;S Daneshmand;D Quinn;J Meeks;S Lerner;D Petrylak;D McConkey;T Flaig;IM Thompson;A Goldkorn
Journal / Conference
European Urology Oncology Apr 20;S2588-9311(23)00074-3
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37087309
PMC
PMC10587361
Study Number(s)
S1314

Risk Prediction of Hepatitis B or C or HIV Among Newly Diagnosed Cancer Patients

Authors
JM Unger;C Till;JP Hwang;KB Arnold;DL Hershman;SD Ramsey
Journal / Conference
Journal of the National Cancer Institute Jun 8;115(6):703-711
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID36946291
PMC
PMC10248838
Study Number(s)
S1204

Interrupting Endocrine Therapy to Attempt Pregnancy After Breast Cancer

Authors
AH Partridge;S Niman;M Ruggeri;F Peccatori;H Azim;M Colleoni;C Saura;C Shimizu;A Saetersdal;J Kroep;A Mailliez;E Warner;V Borges;F Amant;A Gombos;A Kataoka;C Rousset;S Borstnar;J Takei;J Lee;J Walshe;M Ruiz Borrego;HCF Moore;C Saunders;V Bjelic-Radisic;S Susnjar;F Cardoso;K Smith;T Ferreiro;K Ribi;K Ruddy;R Kammler;S El-Abed;G Viale;M Piccart;L Korde;A Goldhirsch;R Gelber;O Pagani
Journal / Conference
New England Journal of Medicine May 4;388(18):1645-1656
Year
2023
Research Committee(s)
Breast and Cancer Survivorship
PMID
PMID37133584
PMC
PMC10358451
Study Number(s)
CTSU/A221405

Do I Know You? Patient Privacy and Consent in the Age of Social Media

Authors
J Sommers;A Mercurio
Journal / Conference
JCO Oncology Practice Feb;19(2):Feb;19(2):
Year
2023
PMID
PMID36480776

Alliance A031902 (CASPAR): A randomized, phase 3 trial of enzalutamide (ENZ) with rucaparib (RUCA)/placebo (PBO) in first-line metastatic castration-resistant prostate cancer (mCRPC)

Authors
A Rao;G Heller;C Ryan;D Vanderweele;L Lewis;A Tan;C Watt;R Chen;M Kohli;P Barata;B Gartrell;R Grubb;A Dueck;Y Wen;M Morris
Journal / Conference
J Clin Oncol 41, 2023 (suppl 6; abstr TPS277); ASCO GU Cancers Symposium (Feb 16-18, 2023, San Francisco, CA), poster
Year
2023
Research Committee(s)
Genitourinary

Evaluating the impact of stratification, sample size, and randomization ratio on the power of randomized Phase 2 clinical trials

Authors
A Moseley;M LeBlanc;M Othus
Journal / Conference
Society for Clinical Trials (May 21-24, 2023, Baltimore, MD), poster
Year
2023
Research Committee(s)
Cancer Care Delivery

Randomized Phase II Trial of Olaparib + Pembrolizumab vs Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 (gBRCA1/2+) Mutations: SWOG S2001 NCT04548752

Authors
V Chung;K Guthrie;M Pishvaian;K Reiss;A Lowy;D Sohal;S Colby;E Sharon;C Allegra;E O'Reilly;E Chiorean;P Philip
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr TPS4198); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), TIP poster session
Year
2023
Research Committee(s)
Gastrointestinal
Study Number(s)
S2001